🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Kidney Transplant Rejection

A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant NCT07508787Phase 214 sites📍 Sacramento📍 Tampa📍 Atlanta Nefro Avillion Clinical Development, LLC · Tests: Siplizumab, Rabbit anti-thymocyte globulin Detection of Circulating Kidney DNA in Kidney Transplant Patients Facing an Episode of Graft Rejection NCT06351488n/a3 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients NCT06910527n/a1 site📍 Rouen Poulet Geoffroy Daratumumab for Late Antibody-Mediated Rejection NCT07081126NA1 site📍 Martin University Hospital, Martin · Tests: Daratumumab (Subcutaneously), control group A Multicenter Randomized Controlled Trial to Treat Acute T Cell Mediated Rejection in Kidney and Kidney-Pancreas Transplant Recipients NCT06474273Phase 330 sites📍 Lambton📍 Randwick📍 Westmead University of Sydney · Tests: Methylprednisolone, Prednisone Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients NCT04702022NA1 site📍 Liège University of Liege · Tests: 18FDG PET / CT Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation NCT06794970n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Trifecta-Kidney cfDNA-MMDx Study NCT04239703n/a31 sites📍 Tampa📍 Baltimore📍 Baltimore University of Alberta · Tests: MMDx, Prospera, HLA antibody Tacrolimus Pharmacokinetic Subpopulations NCT04526431n/a2 sites📍 Grenoble📍 Saint-Etienne University Hospital, Grenoble · Tests: Dosage Forms Oral Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation. NCT04870437NA4 sites📍 Besançon📍 Clermont-Ferrand📍 Saint-Etienne University Hospital, Angers · Tests: Extracorporeal phototherapy Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients NCT01531257n/a1 site📍 Chicago Northwestern University A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients NCT05325008Phase 313 sites📍 Canberra📍 New Lambton Heights📍 Randwick The University of Queensland · Tests: Immunosuppression reduction/modification + intravenous immunoglobulin, Immunosuppression reduction/modification Evaluation of the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients" NCT06406179NA6 sites📍 Paris📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: dd-cfDNA-guided Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity NCT07134491n/a2 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Piece of kidney removal, Stool collection, Blood collection A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation NCT07412470Phase 2, Phase 373 sites📍 San Francisco📍 Atlanta📍 Hines Sanofi · Tests: Frexalimab, Frexalimab, Tacrolimus, rabbit anti-thymocyte globulin, mycophenolate mofetil Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation NCT05600634n/a3 sites📍 Xi'an📍 Hangzhou📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Skin allotransplantation Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized NCT07539857Phase 21 site📍 Leiden Leiden University Medical Center · Tests: Belimumab Prefilled Syringe [Benlysta] Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection NCT05084768n/a1 site📍 Loma Linda Loma Linda University · Tests: Donor-derived cell-free DNA Mycophenolate-Based Therapy for Kidney Transplant Recipients Without HLA-DQ Mismatch NCT06493526Phase 41 site📍 Edegem University Hospital, Antwerp · Tests: Withdrawal of calcineurin-inhibitor, continue on concentration-controlled mycophenolate mofetil and corticosteroids. REgulatory T Cell Therapy to Achieve Immunosuppression REduction NCT06552169Phase 27 sites📍 Phoenix📍 Chicago📍 Rochester Singulera Therapeutics Inc. · Tests: Arm 1: SOC (mTOR + CNI), Arm 2A: TRACT/MONO mTOR, Arm 2B: TRACT/MONO CNI CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk NCT07053462Phase 1, Phase 21 site📍 Beijing AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · Tests: Ex Vivo CRISPR-Cas9 Gene Editing of Donor Kidney, Kidney Transplantation with Standard Care Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) NCT06263426NA18 sites📍 Birmingham📍 Sacramento📍 San Diego Johns Hopkins University · Tests: HIV D+/R+, HIV D-/R+ Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection NCT03955172NA1 site📍 Lyon Hospices Civils de Lyon · Tests: Everolimus KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection NCT06830473n/a2 sites📍 Edinburgh📍 Glasgow University of Edinburgh Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor NCT03707262Phase 1, Phase 21 site📍 Los Angeles Jeffrey Veale, MD · Tests: Donor CD34+ and CD3+ cells Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants NCT05525507Phase 11 site📍 Los Angeles University of California, Los Angeles · Tests: Conditioning and Stem cell infusion VEL-101 to Prevent Rejection After Kidney Transplantation NCT07290777Phase 21 site📍 Dallas Veloxis Pharmaceuticals · Tests: Tacrolimus (TAC), VEL-101 Use of Extracorporeal Photopheresis in Kidney Transplantation: Effects on Antibody-Mediated Rejection NCT07663669n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Platelet Aggregation in the Diagnosis of Acute Graft Rejection NCT07275541n/a1 site📍 Martin University Hospital, Martin Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies NCT05385432Phase 31 site📍 Tours University Hospital, Tours · Tests: Rabbit Anti thymocyte globulin (rATG), Basiliximab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy